See more : Kumho Tire Co., Inc. (073240.KS) Income Statement Analysis – Financial Results
Complete financial analysis of The Joint Corp. (JYNT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Joint Corp., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Groupe Airwell Société anonyme (MLAIR.PA) Income Statement Analysis – Financial Results
- China Tungsten And Hightech Materals Co.,Ltd (000657.SZ) Income Statement Analysis – Financial Results
- ETAO International Co., Ltd. (ETAOF) Income Statement Analysis – Financial Results
- Transtech Optelecom Science Holdings Limited (9963.HK) Income Statement Analysis – Financial Results
- CDL Hospitality Trusts (J85.SI) Income Statement Analysis – Financial Results
The Joint Corp. (JYNT)
About The Joint Corp.
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 117.70M | 101.91M | 81.19M | 58.68M | 48.45M | 31.79M | 25.16M | 20.52M | 13.84M | 7.12M | 5.96M | 2.78M |
Cost of Revenue | 10.55M | 9.83M | 8.51M | 6.51M | 5.57M | 4.31M | 3.31M | 2.94M | 2.82M | 2.25M | 2.01M | 1.09M |
Gross Profit | 107.15M | 92.08M | 72.68M | 52.18M | 42.88M | 27.48M | 21.85M | 17.58M | 11.02M | 4.87M | 3.95M | 1.69M |
Gross Profit Ratio | 91.04% | 90.35% | 89.51% | 88.91% | 88.51% | 86.44% | 86.84% | 85.68% | 79.62% | 68.43% | 66.33% | 60.84% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 343.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 81.47M | 67.99M | 49.12M | 36.20M | 30.54M | 20.30M | 18.12M | 22.10M | 15.37M | 5.10M | 2.66M | 2.24M |
Selling & Marketing | 16.54M | 13.96M | 11.42M | 7.80M | 6.91M | 4.82M | 4.47M | 4.42M | 3.69M | 1.19M | 781.26K | 748.92K |
SG&A | 98.01M | 81.95M | 60.55M | 44.00M | 37.46M | 25.12M | 22.59M | 26.52M | 19.06M | 6.29M | 3.44M | 2.99M |
Other Expenses | 11.21M | 7.64M | 6.09M | 2.73M | 1.90M | -47.77K | -64.46K | 13.30K | 22.12K | -64.08K | -32.00K | 36.32K |
Operating Expenses | 109.22M | 89.59M | 66.64M | 46.73M | 39.36M | 26.68M | 24.61M | 29.09M | 20.33M | 6.50M | 3.51M | 3.04M |
Cost & Expenses | 119.77M | 99.42M | 75.15M | 53.24M | 44.92M | 30.99M | 27.92M | 32.03M | 23.15M | 8.74M | 5.52M | 4.13M |
Interest Income | 0.00 | 133.10K | 69.88K | 79.48K | 61.52K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 67.46K | 953.53K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.00K | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 8.58M | 6.65M | 6.09M | 2.73M | 1.90M | 1.56M | 2.02M | 2.57M | 1.27M | 210.12K | 70.73K | 49.81K |
EBITDA | 9.14M | 7.89M | 12.16M | 8.18M | 5.43M | 2.29M | -896.78K | -8.85M | -7.76M | -1.42M | 510.51K | -1.30M |
EBITDA Ratio | 7.77% | 10.34% | 14.98% | 13.84% | 11.40% | 9.10% | -1.28% | -26.39% | -60.05% | -19.91% | 8.57% | -46.58% |
Operating Income | -2.07M | 2.90M | 6.01M | 5.49M | 3.41M | 205.11K | -3.17M | -15.02M | -9.32M | -1.63M | 439.79K | -1.35M |
Operating Income Ratio | -1.76% | 2.84% | 7.40% | 9.36% | 7.05% | 0.65% | -12.62% | -73.20% | -67.34% | -22.86% | 7.38% | -48.37% |
Total Other Income/Expenses | 3.71M | -133.10K | -187.33K | -79.48K | -42.22K | -33.59K | -64.46K | -1.47K | 283.27K | -64.08K | -32.00K | 36.32K |
Income Before Tax | 1.64M | 1.94M | 5.94M | 5.41M | 3.37M | 215.36K | -3.24M | -15.01M | -9.03M | -1.69M | 407.79K | -1.31M |
Income Before Tax Ratio | 1.39% | 1.91% | 7.31% | 9.22% | 6.96% | 0.68% | -12.87% | -73.13% | -65.29% | -23.76% | 6.84% | -47.07% |
Income Tax Expense | 11.39M | 766.51K | -1.22M | -7.75M | 48.71K | -37.73K | 35.88K | 164.43K | -235.86K | 1.34M | 252.15K | -574.53K |
Net Income | -9.75M | 1.18M | 7.57M | 13.17M | 3.32M | 253.08K | -3.28M | -15.17M | -8.80M | -3.03M | 155.64K | -736.30K |
Net Income Ratio | -8.29% | 1.16% | 9.32% | 22.44% | 6.86% | 0.80% | -13.02% | -73.93% | -63.59% | -42.59% | 2.61% | -26.44% |
EPS | -0.66 | 0.08 | 0.46 | 0.94 | 0.24 | 0.02 | -0.25 | -1.20 | -0.88 | -0.56 | 0.02 | -0.08 |
EPS Diluted | -0.66 | 0.08 | 0.44 | 0.90 | 0.23 | 0.02 | -0.25 | -1.20 | -0.88 | -0.56 | 0.02 | -0.08 |
Weighted Avg Shares Out | 14.69M | 14.49M | 14.32M | 14.00M | 13.82M | 13.67M | 13.20M | 12.64M | 10.00M | 5.41M | 9.17M | 9.17M |
Weighted Avg Shares Out (Dil) | 14.69M | 14.87M | 14.94M | 14.58M | 14.47M | 14.03M | 13.25M | 12.70M | 10.04M | 5.45M | 9.17M | 9.17M |
The9 Joint Venture Partner Increased Committed Annual Revenue to RMB900 Million and Profit to RMB300 Million from RMB600 and RMB200M Respectively
Lockheed Wins Contract for F-35 Joint Strike Fighter Jet Program
GM Taking More Than $5B Hit on Joint Venture in China
GM Writes Down Chinese Joint Venture. It's a Warning for American Car Makers.
Rosen Law Firm Encourages Joint Stock Company Kaspi.kz Investors to Inquire About Securities Class Action Investigation - KSPI
Jeffs' Brands and Deliverz.AI Sign a Binding Letter of Intent for a U.S. Joint Venture Involving AI-Powered Fully Autonomous Robots
Inari Medical Announces Joint Venture in Greater China
Denison Mines Enters Deal to Form 3 Uranium Joint Ventures With Cosa
Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management
Rosen Law Firm Encourages Joint Stock Company Kaspi.kz Investors to Inquire About Securities Class Action Investigation - KSPI
Source: https://incomestatements.info
Category: Stock Reports